VBIV · VBI Vaccines
Acquired Company
VBI Vaccines was acquired by K2 VBI Equity Trust, LLC on January 3, 2025.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.
160 SECOND STREET, CAMBRIDGE, MA, UNITED STATES, 02142, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
1.873M
52 Wk Range
$0.00 - $0.00
Previous Close
$0.07
Open
$0.07
Volume
N/A
Day Range
$0.07 - $0.07
Enterprise Value
N/A
Cash
12.6M
Avg Qtr Burn
-11.77M
Insider Ownership
6.77%
Institutional Own.
13.04%
Qtr Updated
Mar 31st 2024